Skip to main content

Groundbreaking Research

Addiction ResearchResearch efforts at the Kahlert Institute focus on the development and testing of novel interventions. These can include behavioral therapies, drugs, and innovative technologies to reduce cravings, drug use, and other complications of addiction.

Preclinical research studies employ a variety of techniques, including behavioral, neurophysiological, genetic, molecular, and computational approaches in investigating drugs as diverse as opioids, cocaine, amphetamines, cannabis, nicotine, and alcohol.

Current Directions of Study